These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2473597)

  • 21. Insulin-like growth factors and their binding proteins in patients with growth hormone receptor deficiency: suggestions for new diagnostic criteria. The Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Blum WF; Ranke MB; Savage MO; Hall K
    Acta Paediatr Suppl; 1992 Sep; 383():125-6. PubMed ID: 1281023
    [No Abstract]   [Full Text] [Related]  

  • 22. The measurement of insulin-like growth factor I: clinical applications and significance.
    Teale JD; Marks V
    Ann Clin Biochem; 1986 Jul; 23 ( Pt 4)():413-24. PubMed ID: 3094423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
    Blethen SL; Daughaday WH; Weldon VV
    J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A child with phenotypic Laron dwarfism and normal somatomedin levels.
    Pintor C; Loche S; Cella SG; Müller EE; Baumann G
    N Engl J Med; 1989 Feb; 320(6):376-9. PubMed ID: 2913494
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of blood insulin-like growth factors and its clinical significance].
    Saito S; Watanabe N; Inoue T
    Nihon Rinsho; 1986 Jan; 44(1):229-36. PubMed ID: 3514996
    [No Abstract]   [Full Text] [Related]  

  • 26. A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I.
    Blum WF; Ranke MB; Bierich JR
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):374-80. PubMed ID: 2455951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency.
    Ranke MB; Gruhler M; Rosskamp R; Brügmann G; Attanasio A; Blum WF; Bierich JR
    Eur J Pediatr; 1986 Dec; 145(6):485-92. PubMed ID: 2880720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of hypothyroidism on growth, serum growth hormone, the growth hormone-dependent somatomedin, insulin-like growth factor, and its carrier protein in rats.
    Burstein PJ; Draznin B; Johnson CJ; Schalch DS
    Endocrinology; 1979 Apr; 104(4):1107-11. PubMed ID: 436752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factors in patients with nonislet cell tumors and hypoglycemia.
    Merimee TJ
    Metabolism; 1986 Apr; 35(4):360-3. PubMed ID: 2421134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Protein and polypeptide growth factors--somatomedin and insulin-like growth factor].
    Sasaki N; Matsuzaki F
    Nihon Rinsho; 1986 Jan; 44(1):69-76. PubMed ID: 3007809
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation.
    Soliman AT; Hassan AE; Aref MK; Hintz RL; Rosenfeld RG; Rogol AD
    Pediatr Res; 1986 Nov; 20(11):1122-30. PubMed ID: 3099250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth and somatomedin responses to growth hormone in Down's syndrome.
    Annerén G; Sara VR; Hall K; Tuvemo T
    Arch Dis Child; 1986 Jan; 61(1):48-52. PubMed ID: 2937371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Growth hormone for therapy of development disorders in pediatric patients with hemodialysis for chronic kidney failure].
    Shizume K; Kawaguchi H; Ito K
    Nihon Rinsho; 1991 Dec; 49 Suppl():787-92. PubMed ID: 1725533
    [No Abstract]   [Full Text] [Related]  

  • 34. Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations.
    Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Diamond FB; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Feb; 76(2):417-23. PubMed ID: 7679400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical aspects of GH binding proteins.
    Daughaday WH; Trivedi B
    Acta Endocrinol (Copenh); 1991; 124 Suppl 2():27-32. PubMed ID: 1853678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salt stimulation of serum insulin-like growth factor binding protein activity.
    Palka J; Peterkofsky B
    Anal Biochem; 1988 Dec; 175(2):442-9. PubMed ID: 2467583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone, somatomedin levels and growth regulation in Turner's syndrome.
    Ranke MB; Blum WF; Haug F; Rosendahl W; Attanasio A; Enders H; Gupta D; Bierich JR
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):305-13. PubMed ID: 3687318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The growth hormone dependence of a somatomedin-binding protein in human serum.
    White RM; Nissley SP; Moses AC; Rechler MM; Johnsonbaugh RE
    J Clin Endocrinol Metab; 1981 Jul; 53(1):49-57. PubMed ID: 6165734
    [No Abstract]   [Full Text] [Related]  

  • 39. [A case of leprechaunism with disorders of insulin-like growth factor-I(IGF-I)/somatomedin C(SMC) binding protein and its receptor].
    Funakoshi T; Morikawa H; Yamasaki A; Kobayashi A; Ueda Y; Mochizuki M; Matsuo M; Nakamura H; Matsuo T; Itoh H
    Nihon Naibunpi Gakkai Zasshi; 1989 Feb; 65(2):99-112. PubMed ID: 2472974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulinlike growth factors in patients with active nephrotic syndrome.
    Garin EH; Grant MB; Silverstein JH
    Am J Dis Child; 1989 Jul; 143(7):865-7. PubMed ID: 2741864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.